Journals / Glokom Katarakt / 2021 / Cilt: 16 - Sayı: 4

Can the Neutrophil-Lymphocyte Ratio be Used as a Biomarker in Patients with Primary or Recurrent Pterygium?

Pages
194–197
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the NLR can be used as a reliable, simple, and inexpensive biomarker of recurrent pterygium

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The purpose of this study was to evaluate the inflammatory state in patients with primary or recurrent pterygium by utilizing the neutrophils-lymphocytes ratio (NLR).
📊
Key Findings & Data:Results: The study enrolled 374 patients, including 178 patients with primary pterygium, 178 patients as controls, and 18 patients with recurrent pterygium.
💡
Conclusion & Impact:However, the NLR can be used as a reliable, simple, and inexpensive biomarker of recurrent pterygium
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The purpose of this study was to evaluate the inflammatory state in patients with primary or recurrent pterygium by utilizing the neutrophils-lymphocytes ratio (NLR). Materials and Methods:We reviewed the medical records of the patients diagnosed with primary or recurrent pterygium retrospectively. The control group comprised of randomly selected patients who underwent strabismus or blepharoplasty surgery. Complete blood count values were obtained from routine preoperative laboratory examinations in the study and control groups. The NLR was calculated by dividing the neutrophils count by the lymphocytes count. Results: The study enrolled 374 patients, including 178 patients with primary pterygium, 178 patients as controls, and 18 patients with recurrent pterygium. The average NLR was markedly higher in the recurrent pterygium group compared to the other groups (p=0.016). The primary pterygium and control groups were similar with respect to the mean NLR (p= 1.000). The area under the receiver operating characteristic (AUROC) curve value of the NLR, which distinguished patients with recurrent pterygium from those with primary pterygium, was found to be 0.699. The best cutoff value was 1.92, with a sensitivity of 77.8% and a specificity of 60.1%. Conclusion: Patients with recurrent pterygium showed a higher NLR compared to those in the other groups. The NLR is not a reliable biomarker of primary pterygium. However, the NLR can be used as a reliable, simple, and inexpensive biomarker of recurrent pterygium

🔖

Cite This Article

Güngel, H., Çubuk, M. Ö., Filik, A., Üçtepe, F. (2022). Can the Neutrophil-Lymphocyte Ratio be Used as a Biomarker in Patients with Primary or Recurrent Pterygium?. Glokom Katarakt, Cilt: 16 - Sayı: 4, 194–197. https://ajindex.com/articles/525732

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Chui J, Di Girolamo N, Wakefield D, et al. The pathogenesis of pterygium: Current concepts and their therapeutic implications. Ocul Surf 2008 6: 24-43
  2. Bradley JC, Yang W, Bradley RH, et al. The science of pterygia. Br J Ophthalmol 2010; 94:815
  3. Taylor HR, West SK, Rosenthal FS, et al. Corneal changes associated with chronic UV irrradiation. Arch Ophthalmol. 1989;107:1481-4
  4. Tsai YY, Cheng YW, Lee H, et al. Oxidative DNA damage in pterygium. Mol Vis. 2005 11:71-5
  5. Wei-Ping Zhou, Yuan-Fang Zhu, Bei Zhang, et al. The Role of Ultraviolet Radiation in the Pathogenesis of Pterygia (Review) Mol Med Rep. 2016;14:3-15
  6. Essex RW, Snibson GR, Daniell M, et al Amniotic membrane grafting in the surgical management of primary pterygium. Clin Exp Ophthalmol 2004; 32:501-4
  7. Young AL. The use of conjunctival rotational autograft in the management of Pterygium. Asia Pac J Ophthalmol (Phila) 2013; 2:209-10
  8. Young AL, Ho M, Jhanji V, Cheng LL. Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology 2013; 120:2390-5
  9. Young AL, Cao D, Chu WK, et al. The evolving story of pterygium. Cornea 2018; 37: (suppl 1): S55-S57
  10. Kaufman SC, Jacobs DS, Lee WB, et al. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology 2013; 120:201-8
  11. Aydemir O, Çatak O, Primer Pterjiyum Cerrahisinde Çıplak Sklera ve Konjonktival Otogreftleme Yönteminin Karşılaştırılması Fırat Tıp Dergisi 2011; 16: 129-31 12. Hovanesian JA, Starr CE, Vroman DT, The ASCRS Cornea Clinical Committee Surgical techniques and adjuvants for the management of primary and recurrent pterygia. J Cataract Refract Surg. 2017;43:405-19
  12. Kim KW, Kim JC. Current approaches and future directions in the management of pterygium. Int J Ophthalmol. 2018;11:709- 11
  13. Zahorec R Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic in flammation and stress in critically ill. Bratisl Lek Listy 2001;102:5-14
  14. Ilhan N, Daglioglu MC, Ilhan O, et al. Assessment of neutrophil/lymphocyte ratio in patients with age-related macular degeneration. Ocul Immunol In flamm. 2015;23:287- 90
  15. Karaca EE, Özmen MC, Ekici F, et al. Neutrophil-to- lymphocyte ratio may predict progression in patients with keratoconus. Cornea. 2014;33:1168-73
  16. Elbey B, Yazgan UC, Yildirim A, et al. Mean platelet volume and neutrophil to lymphocyte ratio in